FR940523-2-00071 FR940523-2-00040 References 1. Arthritis Medical Information Series: Sjogren's Syndrome. Atlanta: Arthritis Foundation, 1988. 2. Peterson JK. Xerostomia. Scand J. Rheumatol 1986;61(suppl):185_189. 3. Steller M, Chou L, Daniels TE. Electrical stimulation of salivary flow in patients with Sjogren's syndrome. J Dent Res. 1988;67(60):1334_1337. 4. Fox PC, Baum BJ, Mandel ID. Pilocarpine for the treatmnt of xerostomia associated with salivary gland dysfunction. Oral Surg 1986;61(3):243_248. 5. Fox PC, van der Ven PF, Sonies BC, et al. Xerostomia: Evaluation of a symptom with increasing significance. J Am Dent Assoc. 1985;110:519_525. 6. Rhodus NL. Xerostomia: An increasingly significant dental management challenge. Northwest Dentistry 1987;66(4):14&hyph;18. 7. Weiss WW, Brennan HS, Katz P, et al. Use of electronic stimulator for the treatment of dry mouth, J Oral Maxilo-fac Surg 1986;41:845_850. 8. Talal N. Sjogren's syndrome, in Wyngaarden JB, Smith LH (Eds): Cecil Textbook of Medicine (17th ed). Philadelphia: Saunders, 1985, pp. 1936_1937. 9. Whaley K, Alspaugh MA. Sjogren's syndome, in Kelly WN, Harris ED, Ruddy s, et al(Eds): Textbook of Rheumatology (vol 1). Philadelphia: Saunders, 1985, pp. 956_973. 10. Weerkamp AH, Wagner K, Vissinic A, et al. Effect of the application of a mucin-based saliva substitute on the oral microflora of xerostomic patients. Oral Pathol 1987;16(9):474_478. 11. Scully C. Sjogren's syndrome: Clinical and laboratory features, immunopathogenesis, and management. Oral surg 1986;62(5):510_523. 12. Fox PC, Busch KA, Baum BJ. Subjective reports of xerostomic and objective measures of salivary gland performance. J Am Dent Assoc 1987;115:581_584. 13. Talal N. Overview of Sjogren's syndrome. J Dent Res 1987;66(special issue): 672_674. 14. Vissink A, Johannes's-Gravenmade E, Panders AK, et al. Treatment of Hyposalivation. Ear Nose Throat J 1988;67:179_185. 15. Levine MJ, Aquirre A, Hatton MN, et al. Artificial salivas: Present and future. J Dent Res 1987;66:693_698. 16. Brastings ED. Saliva, xerostomia, and salivary substitutes. Pa Dent J 1987;54(5):23_24. 17. Duxbury AJH, Thakker NS, Wastell DG. A double-blind cross-over trial of a mucin-containing artificial saliva. Br Dent J 1989;166:115_120. 18. Vissink KA, Panders AK,'sGravenmade EJ, et al. Treatment of oral symptoms in Sjogren's syndrome. Scand J Rheumatol 1986;61(suppl):270_273. 19. Garrett JR. The proper role of nerves in salivary secretion: A review. J Dent Res 1987;66(2):387_397. 20. Food and Drug Administration. Summary of Safety and Effectiveness Data: Salivation Electro-Stimulation Device, (unpublished report), 1988. [FR Doc. 94&hyph;12457 Filed 5&hyph;20&hyph;94; 8:45 am] BILLING CODE 4121&hyph;01&hyph;P
